High-resolution genomic and expression analyses of copy number alterations in breast tumors
- 1 June 2008
- journal article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 47 (6), 530-542
- https://doi.org/10.1002/gcc.20558
Abstract
Analysis of recurrent DNA amplification can lead to the identification of cancer driver genes, but this process is often hampered by the low resolution of existing copy number analysis platforms. Fifty‐one breast tumors were profiled for copy number alterations (CNAs) with the high‐resolution Affymetrix 500K SNP array. These tumors were also expression‐profiled and surveyed for mutations in selected genes commonly mutated in breast cancer (TP53, CDKN2A, ERBB2, KRAS, PIK3CA, PTEN). Combined analysis of common CNAs and mutations revealed putative associations between features. Analysis of both the prevalence and amplitude of CNAs defined regions of recurrent alteration. Compared with previous array comparative genomic hybridization studies, our analysis provided boundaries for frequently altered regions that were approximately one‐fourth the size, greatly reducing the number of potential alteration‐driving genes. Expression data from matched tumor samples were used to further interrogate the functional relevance of genes located in recurrent amplicons. Although our data support the importance of some known driver genes such as ERBB2, refined amplicon boundaries at other locations, such as 8p11‐12 and 11q13.5‐q14.2, greatly reduce the number of potential driver genes and indicate alternatives to commonly suggested driver genes in some cases. For example, the previously reported recurrent amplification at 17q23.2 is reduced to a 249 kb minimal region containing the putative driver RPS6KB1 as well as the putative oncogenic microRNA mir‐21. High‐resolution copy number analysis provides refined insight into many breast cancer amplicons and their relationships to gene expression, point mutations and breast cancer subtype classifications. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat.Keywords
This publication has 41 references indexed in Scilit:
- Assessing the significance of chromosomal aberrations in cancer: Methodology and application to gliomaProceedings of the National Academy of Sciences of the United States of America, 2007
- MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeGenome Biology, 2007
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Using array-comparative genomic hybridization to define molecular portraits of primary breast cancersOncogene, 2006
- Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancerGenes, Chromosomes and Cancer, 2006
- MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma CellsCancer Research, 2005
- Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic CancerNeoplasia, 2005
- Profiling Breast Cancer by Array CGHBreast Cancer Research and Treatment, 2003
- Detecting Activation of Ribosomal Protein S6 Kinase by Complementary DNA and Tissue Microarray AnalysisJNCI Journal of the National Cancer Institute, 2000
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingJournal of the Royal Statistical Society: Series B (Methodological), 1995